Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study

Dirk De Ruysscher; Angela van Baardwijk; Jessie Steevens; Anita Botterweck; Geert Bosmans; Bart Reymen; Rinus Wanders; Jacques Borger; Anne-Marie C. Dingemans; Gerben Bootsma; Cordula Pitz; Ragnar Lunde; Wiel Geraedts; Michel Oellers; Andre Dekker; Philippe Lambin

doi:10.1016/j.radonc.2011.10.010

Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study

Dirk De Ruysscher, Angela van Baardwijk, Jessie Steevens, Anita Botterweck, Geert Bosmans, Bart Reymen, Rinus Wanders, Jacques Borger, Anne-Marie C. Dingemans, Gerben Bootsma, Cordula Pitz, Ragnar Lunde, Wiel Geraedts, Michel Oellers, Andre Dekker, Philippe Lambin

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	228-233
Journal	Radiotherapy and Oncology
Volume	102
Issue number	2
DOIs	https://doi.org/10.1016/j.radonc.2011.10.010
Publication status	Published - Feb 2012

Keywords

Non-small cell lung cancer
Radiotherapy
Chemotherapy
Stage III
Combined modality treatment
Individualised

Access to Document

10.1016/j.radonc.2011.10.010

Cite this

De Ruysscher, D., van Baardwijk, A., Steevens, J., Botterweck, A., Bosmans, G., Reymen, B., Wanders, R., Borger, J., Dingemans, A-M. C., Bootsma, G., Pitz, C., Lunde, R., Geraedts, W., Oellers, M., Dekker, A., & Lambin, P. (2012). Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study. Radiotherapy and Oncology, 102(2), 228-233. https://doi.org/10.1016/j.radonc.2011.10.010

De Ruysscher, Dirk ; van Baardwijk, Angela ; Steevens, Jessie ; Botterweck, Anita ; Bosmans, Geert ; Reymen, Bart ; Wanders, Rinus ; Borger, Jacques ; Dingemans, Anne-Marie C. ; Bootsma, Gerben ; Pitz, Cordula ; Lunde, Ragnar ; Geraedts, Wiel ; Oellers, Michel ; Dekker, Andre ; Lambin, Philippe. / Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study. In: Radiotherapy and Oncology. 2012 ; Vol. 102, No. 2. pp. 228-233.

@article{e5ccf08f11884c51b34ca94d2ea486cd,

title = "Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study",

keywords = "Non-small cell lung cancer, Radiotherapy, Chemotherapy, Stage III, Combined modality treatment, Individualised",

author = "{De Ruysscher}, Dirk and {van Baardwijk}, Angela and Jessie Steevens and Anita Botterweck and Geert Bosmans and Bart Reymen and Rinus Wanders and Jacques Borger and Dingemans, {Anne-Marie C.} and Gerben Bootsma and Cordula Pitz and Ragnar Lunde and Wiel Geraedts and Michel Oellers and Andre Dekker and Philippe Lambin",

year = "2012",

month = feb,

doi = "10.1016/j.radonc.2011.10.010",

language = "English",

volume = "102",

pages = "228--233",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

number = "2",

}

De Ruysscher, D, van Baardwijk, A, Steevens, J, Botterweck, A, Bosmans, G, Reymen, B, Wanders, R, Borger, J, Dingemans, A-MC, Bootsma, G, Pitz, C, Lunde, R, Geraedts, W, Oellers, M, Dekker, A & Lambin, P 2012, 'Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study', Radiotherapy and Oncology, vol. 102, no. 2, pp. 228-233. https://doi.org/10.1016/j.radonc.2011.10.010

Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study. / De Ruysscher, Dirk; van Baardwijk, Angela; Steevens, Jessie; Botterweck, Anita; Bosmans, Geert; Reymen, Bart; Wanders, Rinus; Borger, Jacques; Dingemans, Anne-Marie C.; Bootsma, Gerben; Pitz, Cordula; Lunde, Ragnar; Geraedts, Wiel; Oellers, Michel; Dekker, Andre ; Lambin, Philippe.

In: Radiotherapy and Oncology, Vol. 102, No. 2, 02.2012, p. 228-233.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study

AU - De Ruysscher, Dirk

AU - van Baardwijk, Angela

AU - Steevens, Jessie

AU - Botterweck, Anita

AU - Bosmans, Geert

AU - Reymen, Bart

AU - Wanders, Rinus

AU - Borger, Jacques

AU - Dingemans, Anne-Marie C.

AU - Bootsma, Gerben

AU - Pitz, Cordula

AU - Lunde, Ragnar

AU - Geraedts, Wiel

AU - Oellers, Michel

AU - Dekker, Andre

AU - Lambin, Philippe

PY - 2012/2

Y1 - 2012/2

KW - Non-small cell lung cancer

KW - Radiotherapy

KW - Chemotherapy

KW - Stage III

KW - Combined modality treatment

KW - Individualised

U2 - 10.1016/j.radonc.2011.10.010

DO - 10.1016/j.radonc.2011.10.010

M3 - Article

VL - 102

SP - 228

EP - 233

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 2

ER -